Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (211-220 of 364) with videos related to

Pageof 37
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2020
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, EnglandZahin Amin-Chowdhury, Felicity Aiano, Anna Mensah, et al.
The Lancet. Child & Adolescent Health|December 9, 2021
Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling studyHelen Campbell, Nick Andrews, Sydel R Parikh, et al.
Vaccine|April 16, 2024
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort studyKonstantinos Karampatsas, Tom Hall, Merryn Voysey, et al.
Vaccine|February 14, 2026
An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy in EnglandKajal Radia, Shari Sapuan, Nicholas Grassly, et al.
The New England Journal of Medicine|January 24, 2020
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandShamez N Ladhani, Nick Andrews, Sydel R Parikh, et al.
Vaccine|February 16, 2023
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health OrganizationDaniel R Feikin, Melissa M Higdon, Nick Andrews, et al.
Emerging Infectious Diseases|September 11, 2024
Mpox Epidemiology and Vaccine Effectiveness, England, 2023Hannah Charles, Katie Thorley, Charlie Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
Vaccine|July 23, 2013
Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in EnglandNigel Field, Gayatri Amirthalingam, Pauline Waight, et al.
Vaccine|October 10, 2021
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in EnglandBerit Muller-Pebody, Mary A Sinnathamby, Fiona Warburton, et al.
Pageof 37

Showing results (211-220 of 364) with videos related to

Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2020
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, EnglandZahin Amin-Chowdhury, Felicity Aiano, Anna Mensah, et al.
The Lancet. Child & Adolescent Health|December 9, 2021
Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling studyHelen Campbell, Nick Andrews, Sydel R Parikh, et al.
Vaccine|April 16, 2024
Antibody kinetics between birth and three months of life in healthy infants with natural exposure to Group B streptococcus: A UK cohort studyKonstantinos Karampatsas, Tom Hall, Merryn Voysey, et al.
Vaccine|February 14, 2026
An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy in EnglandKajal Radia, Shari Sapuan, Nicholas Grassly, et al.
The New England Journal of Medicine|January 24, 2020
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in EnglandShamez N Ladhani, Nick Andrews, Sydel R Parikh, et al.
Vaccine|February 16, 2023
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health OrganizationDaniel R Feikin, Melissa M Higdon, Nick Andrews, et al.
Emerging Infectious Diseases|September 11, 2024
Mpox Epidemiology and Vaccine Effectiveness, England, 2023Hannah Charles, Katie Thorley, Charlie Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, EnglandShamez N Ladhani, Helen Campbell, Nick Andrews, et al.
Vaccine|July 23, 2013
Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in EnglandNigel Field, Gayatri Amirthalingam, Pauline Waight, et al.
Vaccine|October 10, 2021
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in EnglandBerit Muller-Pebody, Mary A Sinnathamby, Fiona Warburton, et al.
Pageof 37